{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Edotecarin",
  "nciThesaurus": {
    "casRegistry": "174402-32-5",
    "chebiId": "",
    "chemicalFormula": "C29H28N4O11",
    "definition": "A synthetic indolocarbazole with antineoplastic activity. Edotecarin inhibits the enzyme topoisomerase I through stabilization of the DNA-enzyme complex and enhanced single-strand DNA cleavage, resulting in inhibition of DNA replication and decreased tumor cell proliferation.",
    "fdaUniiCode": "1V8X590XDP",
    "identifier": "C2665",
    "preferredName": "Edotecarin",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C1904"
    ],
    "synonyms": [
      "6-N-(1-hydroxymethyla-2-hydroxy)ethylamino-12,13-dihydro-13-(beta-D-gluco pyranosyl)-5H-indolo[2,3-a]-pyrrolol[3,4-c]-carbazole-5,7(6H)-dione",
      "EDOTECARIN",
      "Edotecarin",
      "J-107088",
      "J107088",
      "edotecarin"
    ]
  }
}